SCHEMBL2960979

SCHEMBL2960979

[CH2]c1ccc(C(=O)N(CC)Cc2ccncc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.58
ALDH1A1 P00352 7/20 0.53
LMNA P02545 2/20 0.52
GFER P55789 1/20 0.52
CYP2C9 P11712 2/20 0.51
CYP2C19 P33261 2/20 0.51
HSD17B10 Q99714 2/20 0.51
MEN1 O00255 2/20 0.51
MAPT P10636 2/20 0.51
KMT2A Q03164 2/20 0.51
CHRM2 P08172 1/20 0.51
CHRM4 P08173 1/20 0.51
CHRM5 P08912 1/20 0.51
CHRM1 P11229 1/20 0.51
CHRM3 P20309 1/20 0.51
BLM P54132 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
TSHR P16473 1/20 0.51
NFKB1 P19838 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17888452 0.86 MMP13 (0.60) USP2ALDH1A1LMNAGFERCYP2C9
SCHEMBL19226522 0.86 USP2 (0.59) USP2ALDH1A1LMNAGFERCYP2C9
SCHEMBL16565835 0.84 USP2 (0.65) USP2ALDH1A1LMNAGFERCYP2C9
SCHEMBL17886720 0.82 USP2 (0.56) USP2ALDH1A1LMNAGFERCYP2C9
SCHEMBL95412 0.82 HDAC1 (0.52) ALDH1A1LMNAMEN1MAPTKMT2A
SCHEMBL5543735 0.82 HPGD (0.61) ALDH1A1LMNAMEN1MAPTKMT2A
SCHEMBL95772 0.81 HDAC1 (0.52) MEN1KMT2AHDAC1HDAC6
SCHEMBL19226524 0.80 USP2 (0.53) USP2ALDH1A1LMNAGFERCYP2C9
SCHEMBL2755872 0.79 USP2 (0.60) USP2ALDH1A1LMNAGFERCYP2C9
SCHEMBL94674 0.78 ALDH1A1 (0.68) ALDH1A1LMNACYP2C9CYP2C19MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20090326008-A1 NF-kappa B Inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-12-31 US disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326008-A1 NF-kappa B Inhibitor NFKBIA, NFKB2, IKBKB USP2 706/4885ALDH1A1 2948/4885LMNA 3740/4885
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 USP2 3071/4885ALDH1A1 2458/4885LMNA 4860/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 USP2 3071/4885ALDH1A1 2458/4885LMNA 4860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.